Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Oncology
Brain Metastases Clinical Trials
A listing of Brain Metastases medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Alabama
University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
Birmingham Alabama 35294-0006
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
University Of Alabama at Birmingham
Birmingham Alabama 35294
A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer
Arkansas
Highlands Oncology Group Dept of Highlands Oncology Grp
Fayetteville Arkansas 72703
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Florida
Memorial Regional Cancer Center Memorial Breast
Hollywood Florida 33021
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
MD Anderson Cancer Center- Orlando
Orlando Florida 32806
A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer
Illinois
University Of Chicago Medical Center
Chicago Illinois 60637
A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer
Ingalls Memorial Hospital Ingalls Mem Hosp
Harvey Illinois 60426
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Maryland
NCI
Rockville Maryland 20892Updated
Patients are needed to participate in a clinical research study of GRN1005 and Trastuzumab to evaluate Breast Cancer or Brain Metastases
Massachusetts
Beth Israel Deaconess Medical Center
Boston Massachusetts 02115
A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors
Dana-Farber Cancer Institute
Boston Massachusetts 02115
A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors
Missouri
Washington University School Of Medicine-Siteman Cancer Ctr WA Siteman
St. Louis Missouri 63110
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
New York
Beth Israel Medical Center BIMC
New York New York 10003
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Memorial Sloan Kettering Cancer Center
New York New York 10065
Patients are needed to participate in a clinical research study evaluating Whole Brain Radiotherapy (WBRT) and Sorafenib for the treatment of Breast Cancer or Brain Metastases
North Carolina
UNC Lineberger Comprehensive Cancer Center
Chapel Hill North Carolina 27599Updated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Duke University Medical Center Duke South 2
Durham North Carolina 27710
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Kinston Medical Specialists, PA
Kinston North Carolina 28501
A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer
Pennsylvania
UPMC Shadyside Radiation Oncology
Pittsburgh Pennsylvania 15232
A Phase 2 clinical study for patients with Brain Metastases or Solid Tumors
Tennessee
Sarah Cannon Research Institute Sarah Cannon Cancer Center SC
Nashville Tennessee 37203
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Vanderbilt-Ingram Cancer Center
Nashville Tennessee 37212
A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer
Texas
UT MD Anderson Cancer Center
Houston Texas 77030Updated
Patients are needed to participate in a clinical research study evaluating TPI 287, Dexamethasone, Benadryl and Ranitidine for the treatment of Breast Cancer
Virginia
University of Virginia
Charlottesville Virginia 22903
A Phase 2 clinical study for patients with HER-2 Positive Breast Cancer
Austria
Medical University of Vienna
Vienna
A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer
Belgium
Universitair Ziekenhuis Antwerpen
Antwerp B-2650Updated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Jules Bordet Institute
Brussels B-1000Updated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Novartis Investigative Site
Liege 4000
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Novartis Investigative Site
Wilrijk 2610
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
China
West China Hospital
Chengdu Sichuan 610041
A clinical research study of icotinib and Whole brain radiotherapy for the treatment of Non-small Cell Lung Cancer or Brain Metastases
The First People's Hospital of Lianyungang
Lianyungang Jiangsu 222002
Patients are needed to participate in a clinical research study of 6MV-X ray and Endostar to evaluate Brain Metastases
Czech Republic
Na Homolce Hospital
Prague
A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer
France
Institut Curie
Paris Paris Cedex 05 75248Updated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Israel
Tel Aviv Sourasky Medical Center
Tel Aviv 64239
A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer
Italy
Ospedale Lecco
Lecco
A clinical trial to evaluate treatments using NovoTTF-100A device and Best Standard of Care for patients with 1-3 Brain Metastases From Non-Small Cell Lung Cancer
Novartis Investigative Site
Modena MO 41100
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Netherlands
Antoni van Leeuwenhoek Ziekenhuis
Amsterdam 1066 CXUpdated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Vrije Universiteit medisch centrum (Vumc)
Amsterdam 1081 HVUpdated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Leids Universitair Medisch Centrum (LUMC)
Leiden 2333 CAUpdated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Maastricht Universitair Medisch Centrum
Maastricht 6229 HXUpdated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Erasmus MC
Rotterdam 3075 EAUpdated
Patients are needed to participate in a clinical research study evaluating 2B3-101, Trastuzumab, 2B3-101 60 mg/m2 every 4 weeks and 2B3-101 50 mg/m2 every 3 weeks
Spain
Novartis Investigative Site
Barcelona Cataluna 08035
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Novartis Investigative Site
Hospitalet de LLobregat Catalunya 08907
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Novartis Investigative Site
Valencia Comunidad Valenciana 46010
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
United Kingdom
Novartis Investigative Site
Brighton East Sussex BN2 5BE
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Novartis Investigative Site
Nottingham NG5 1PB
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+
Novartis Investigative Site
Oxford OX3 7LJ
A clinical trial to evaluate treatments using BKM120 for patients with Metastatic Breast Cancer, Trastuzumab, BKM120 or HER2+